rVSV-SUDV vaccine (Makerere University/Epicentre Centre Mbarara Research Centre/MRC/UVRI and LSHTM Uganda Research Unit)

N/A

Report date: 2025/06/11 11:07:06

Base Information

Drug NamerVSV-SUDV vaccine (Makerere University/Epicentre Centre Mbarara Research Centre/MRC/UVRI and LSHTM Uganda Research Unit)
Drug Alias NamerVSV-SUDVreplicating viral vector-based vaccine (Makerere University/Epicentre Centre Mbarara Research Centre/MRC/UVRI and LSHTM Uganda Research Unit)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUganda
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMakerere University
China Registration ClassN/A

Develop Information

Active CompaniesEpicentreMakerere UniversityMrc/Uvri And Lshtm Uganda Research Unit
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A